262 related articles for article (PubMed ID: 16440805)
1. [Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera].
Sumi M; Tauchi T; Takaku T; Ohyashiki JH; Ohyashiki K
Rinsho Ketsueki; 2005 Nov; 46(11):1208-12. PubMed ID: 16440805
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha therapy in polycythemia vera and essential thrombocythemia.
Elliott MA; Tefferi A
Semin Thromb Hemost; 1997; 23(5):463-72. PubMed ID: 9387205
[TBL] [Abstract][Full Text] [Related]
3. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
[TBL] [Abstract][Full Text] [Related]
4. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
[TBL] [Abstract][Full Text] [Related]
5. [A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].
Harashima S; Okamura T; Umeno M; Takaki K
Rinsho Ketsueki; 1996 Aug; 37(8):713-8. PubMed ID: 8827883
[TBL] [Abstract][Full Text] [Related]
6. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J
J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
8. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
9. Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.
Hélias C; Struski S; Gervais C; Leymarie V; Mauvieux L; Herbrecht R; Lessard M
Cancer Genet Cytogenet; 2008 Jan; 180(1):51-5. PubMed ID: 18068534
[TBL] [Abstract][Full Text] [Related]
10. Megakaryoblastic transformation of polycythemia vera with hypercalcemia.
Kurosawa M; Iwasaki H
Ann Hematol; 2002 Nov; 81(11):668-71. PubMed ID: 12454709
[TBL] [Abstract][Full Text] [Related]
11. Leukemic transformation of polycythemia vera: a single center study of 23 patients.
Passamonti F; Rumi E; Arcaini L; Castagnola C; Lunghi M; Bernasconi P; Giovanni Della Porta M; Columbo N; Pascutto C; Cazzola M; Lazzarino M
Cancer; 2005 Sep; 104(5):1032-6. PubMed ID: 16047334
[TBL] [Abstract][Full Text] [Related]
12. [Interferon-alpha in the treatment of myeloproliferative syndromes].
Ballarino P; Castello G; Lerza R
Recenti Prog Med; 1994 Nov; 85(11):546-50. PubMed ID: 7855389
[TBL] [Abstract][Full Text] [Related]
13. A boy with acute lymphoblastic leukemia acquired clonal and nonclonal cytogenetic abnormalities including del(7q) and del(20q) without clinical evidence of disease after sex-mismatched cord blood transplantation.
Kim IS; Kim HJ; Yoo KH; Sung KW; Kim SH
J Pediatr Hematol Oncol; 2006 Aug; 28(8):540-3. PubMed ID: 16912597
[TBL] [Abstract][Full Text] [Related]
14. [CD7+, CD34+, electronmicroscopically peroxidase-negative acute leukemia transformed from polycythemia vera after 12 years follow-up].
Kuno Y; Takeo T; Kawashima K
Rinsho Ketsueki; 1997 Sep; 38(9):782-7. PubMed ID: 9364871
[TBL] [Abstract][Full Text] [Related]
15. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
[TBL] [Abstract][Full Text] [Related]
16. Risk of leukemic transformation in PV and ET patients.
Chomienne C; Rain JD; Brière J;
Pathol Biol (Paris); 2004 Jun; 52(5):289-93. PubMed ID: 15217716
[TBL] [Abstract][Full Text] [Related]
17. [Megakaryoblastic transformation associated with disseminated intravascular coagulation in the course of polycythemia vera: a case report].
Hino K; Sato S; Sakashita A; Tomoyasu S; Tsuruoka N; Koike T
Rinsho Ketsueki; 1992 Apr; 33(4):500-6. PubMed ID: 1602615
[TBL] [Abstract][Full Text] [Related]
18. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
[TBL] [Abstract][Full Text] [Related]
19. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
20. Expertise-based management in essential thrombocythemia and polycythemia vera.
Finazzi G; Barbui T
Cancer J; 2007; 13(6):372-6. PubMed ID: 18032974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
